4,460,311 Shares in Stryker Corporation $SYK Acquired by Bank of America Corp DE

Key Points

• Bank of America acquired 4.46 million Stryker shares in the second quarter, valued at approximately $1.40 billion and representing about 1.16% of the company. Institutional investors collectively own 77.09% of Stryker.
• Stryker reported quarterly adjusted earnings of $3.69 per share, exceeding estimates by $0.20, while revenue rose 9.4% year over year to $6.59 billion. The company reaffirmed fiscal 2026 EPS guidance of $14.95–$15.10.
• The company declared a quarterly dividend of $0.88 per share, equal to a 1.2% annualized yield. Meanwhile, insiders sold roughly $118.2 million of stock over the past 90 days, and analysts maintained a “Moderate Buy” consensus with an average price target of $380.40.

Bank of America Corp DE acquired a new stake in shares of Stryker Corporation (NYSE:SYK - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 4,460,311 shares of the medical technology company's stock, valued at approximately $1,404,284,000. Bank of America Corp DE owned approximately 1.16% of Stryker as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the stock. Gables Capital Management Inc. bought a new position in Stryker in the 2nd quarter worth about $25,000. Kilter Group LLC purchased a new position in Stryker in the second quarter worth about $25,000. Godfrey Financial Associates Inc. bought a new position in shares of Stryker in the fourth quarter worth approximately $26,000. Sankala Group LLC bought a new position in shares of Stryker in the fourth quarter worth approximately $26,000. Finally, Compass Financial Management LLC purchased a new stake in shares of Stryker during the second quarter valued at approximately $27,000. 77.09% of the stock is owned by institutional investors.

Stryker Trading Up 2.4%

Shares of NYSE:SYK opened at $282.06 on Tuesday. The stock's 50-day simple moving average is $323.77 and its two-hundred day simple moving average is $325.37. The stock has a market capitalization of $108.19 billion, a price-to-earnings ratio of 29.23, a PEG ratio of 1.73 and a beta of 0.76. Stryker Corporation has a 52-week low of $267.00 and a 52-week high of $392.55. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating the consensus estimate of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The firm had revenue of $6.59 billion during the quarter, compared to analyst estimates of $6.58 billion. During the same quarter in the prior year, the firm earned $3.13 EPS. The business's revenue for the quarter was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Analysts expect that Stryker Corporation will post 15.02 EPS for the current year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a $0.88 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 annualized dividend and a yield of 1.2%. Stryker's dividend payout ratio (DPR) is presently 36.48%.

Insiders Place Their Bets

In other news, insider Debra King sold 826 shares of Stryker stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total transaction of $277,783.80. Following the transaction, the insider owned 6,210 shares in the company, valued at $2,088,423. This trade represents a 11.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Ronda Stryker sold 300,000 shares of the business's stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $335.90, for a total transaction of $100,770,000.00. Following the sale, the director directly owned 2,301,375 shares of the company's stock, valued at approximately $773,031,862.50. The trade was a 11.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 351,267 shares of company stock worth $118,197,701. Company insiders own 4.60% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on SYK. Wells Fargo & Company reduced their price target on shares of Stryker from $418.00 to $348.00 and set an "overweight" rating for the company in a research report on Wednesday, September 9th. Weiss Ratings reiterated a "hold (c)" rating on shares of Stryker in a research note on Friday, July 31st. BMO Capital Markets restated an "outperform" rating and issued a $317.00 price target on shares of Stryker in a research note on Wednesday, September 9th. Citigroup lowered their price target on Stryker from $399.00 to $360.00 and set a "buy" rating on the stock in a report on Thursday, September 10th. Finally, Piper Sandler dropped their price objective on Stryker from $420.00 to $390.00 and set an "overweight" rating on the stock in a research report on Friday, July 31st. Eighteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $380.40.

About Stryker

Stryker Corporation is a global medical technology company headquartered in Portage, Michigan. The company develops and manufactures products used by hospitals, physicians and other healthcare providers across a range of medical specialties.

Stryker's principal businesses include orthopaedics, medical and surgical equipment, and neurovascular products. Its offerings include joint replacement and trauma implants, spinal devices, surgical instruments, operating-room equipment, endoscopy systems, surgical navigation technologies, emergency-care products and devices used to treat neurovascular conditions such as stroke.

Founded in 1941 by Dr.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.